MicroRNA Market to Reach USD 7.7 Billion by 2032 and grow at a CAGR of 21.1%.
The market size in the global market for microRNA, or miRNA, is significant as the instances of diseases like cancer, cardiovascular conditions, and neurological disorders have been constantly growing. Such illnesses require advanced and agile types of diagnostics and treatment, and the functions of miRNAs can control gene expression and serve as non-invasive biomarkers; therefore, the introduction of diagnostics involving miRNAs, especially those related to cancer, has only hastened developments in precision medicine with additional applications comprising potential utility to address critical healthcare challenges.